US Broker Ratings

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 2.6% Potential Upside Amid Strong Revenue Growth

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors. With a market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 235% Upside in the Booming Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biopharmaceutical landscape, is capturing attention with its groundbreaking work in cell therapies aimed at treating cancer. With a market capitalization..

ADMA Biologics (ADMA): Analyst Consensus Points to a 43.55% Upside Potential in Biotech

ADMA Biologics Inc (NASDAQ: ADMA) stands out in the biotech sector with a significant promise of growth and development. Founded in 2004 and headquartered in Ramsey, New Jersey, ADMA is..

Incyte Corporation (INCY): Stock Analysis Highlights Strong Revenue Growth and Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a notable player in the biotechnology sector, has been making waves with its impressive revenue growth and promising drug pipeline. With a market capitalization of $19.91..

Natera, Inc. (NTRA) Investor Outlook: Exploring a $31.91 Billion Market Cap and 8.53% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, specifically within diagnostics and research, has captured investor attention with its dynamic approach to molecular testing services. Headquartered in..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and Promising Growth Trajectory

Insmed Incorporated (NASDAQ: INSM) continues to capture investor attention in the healthcare sector, particularly in the biotechnology industry, where it stands out with a significant market capitalization of $37.77 billion...

Bio-Techne Corp (TECH): Investor Outlook on a Stock Poised for 16.79% Upside

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, is capturing investor attention with analysts forecasting a potential 16.79% upside. With its market capitalization standing strong at $9.29..

Royalty Pharma plc (RPRX): Investor Outlook with a 19% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with its unique business model of acquiring biopharmaceutical royalties and funding innovation. As it rides the wave of the..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 15% Upside Potential

In the dynamic landscape of the healthcare sector, Align Technology, Inc. (NASDAQ: ALGN) stands out as a formidable player in the Medical Instruments & Supplies industry. Headquartered in Tempe, Arizona,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its significant growth potential. Headquartered..

CVS Health Corporation (CVS) Stock Analysis: Evaluating an 18% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to captivate investors with its expansive reach and robust market presence. With a current market capitalization of $101.72..

Waystar Holding Corp. (WAY) Stock Analysis: Unlocking a 54% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) presents a compelling case with a striking potential upside of 54.13%. Headquartered in Lehi, Utah,..

Illumina, Inc. (ILMN) Stock Analysis: Can This Genomics Leader Defy Its Potential Downside?

Illumina, Inc. (NASDAQ: ILMN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego, California, Illumina’s core business revolves around providing..

Bruker Corporation (BRKR) Stock Report: Assessing the 8.83% Potential Upside for Investors

Bruker Corporation (NASDAQ: BRKR) is a key player in the healthcare sector, specifically within the medical devices industry, offering a rich portfolio of scientific instruments and analytical solutions. Headquartered in..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Innovator with 138% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector, presenting a compelling opportunity for investors with a notable potential upside of 138.22%. With its innovative approach to..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 14% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a distinguished player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.23 billion, Bio-Rad is a..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Market with 7.84% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands at the crossroads of innovation and opportunity within the healthcare sector, with its latest stock analysis revealing a potential upside of 7.84%. As a key..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with Steady Growth

As an investor in the healthcare sector, understanding the dynamics of companies like Henry Schein, Inc. (NASDAQ: HSIC) is crucial for building a diversified portfolio. With a market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 31.93% Potential Upside

Encompass Health Corporation (NYSE: EHC) has captured the attention of investors with its robust growth prospects and substantial potential upside. Operating in the healthcare sector, EHC specializes in providing post-acute..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 19% Potential Upside in the Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, is increasingly capturing investor attention with its innovative approach to drug discovery and development. The company, which has carved a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds